Tenax Therapeutics (TENX) Goodwill & Intangibles (2011 - 2017)
Tenax Therapeutics (TENX) reported Goodwill & Intangibles of $22.0 million for Q2 2017, down 33.86% on a YoY basis from $33.3 million in Q2 2016, and down 33.86% sequentially from $33.3 million in Q3 2016.
Tenax Therapeutics (TENX) Goodwill & Intangibles (2011 - 2017) Analysis & Trends
Tenax Therapeutics (TENX) has 7 years of Goodwill & Intangibles data on file, last reported at $22.0 million in Q2 2017.
- For the quarter ending Q2 2017, Goodwill & Intangibles fell 33.86% year-over-year to $22.0 million; the trailing twelve-month figure through Jun 2017 stood at $22.0 million (down 33.86% YoY), and the FY2015 full-year result was $11.3 million, changed N/A from the prior year.
- Goodwill & Intangibles slipped to $22.0 million in Q2 2017, from $33.3 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $33.3 million in Q2 2016 to a low of $893358.0 in Q2 2014.
- A 5-year average of $15.8 million and a median of $16.6 million in 2015 frame the typical range for Goodwill & Intangibles.
- Across the five-year window, Goodwill & Intangibles jumped 2535.43% in 2015 and plunged 33.86% in 2017, its largest moves.
- Tracing TENX's Goodwill & Intangibles over 5 years: stood at $924698.0 in 2013, then retreated by 3.39% to $893358.0 in 2014, then jumped by 1160.98% to $11.3 million in 2015, then soared by 195.29% to $33.3 million in 2016, then sank by 33.86% to $22.0 million in 2017.
- Business Quant data shows TENX's Goodwill & Intangibles at $22.0 million in Q2 2017, $33.3 million in Q3 2016, and $33.3 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 22.00 Mn |
| Sep 30, 2016 | 33.27 Mn |
| Jun 30, 2016 | 33.27 Mn |
| Dec 31, 2015 | 11.27 Mn |
| Apr 30, 2015 | 23.54 Mn |
| Apr 30, 2014 | 893,358.00 |
| Apr 30, 2013 | 924,698.00 |
| Jan 31, 2013 | 923,397.00 |
| Oct 31, 2012 | 904,498.00 |
| Jul 31, 2012 | 881,317.00 |
| Apr 30, 2012 | 872,971.00 |
| Jan 31, 2012 | 863,510.00 |
| Oct 31, 2011 | 831,407.00 |
| Jul 31, 2011 | 746,033.00 |
| Apr 30, 2011 | 699,951.00 |